Bristol Myers, Pfizer to Offer Blockbuster Blood Thinner Through Mark ...

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark ...

Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

PRINCETON, N.J.--(BUSINESS WIRE)--Apr 24, 2026-

Bristol Myers Squibb-Pfizer Alliance to sell Eliquis on Mark Cuban’s Cost Plus Drugs

The Bristol Myers Squibb–Pfizer Alliance announced the launch of a collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to offer Eliquis (apixaban) on CostPlusDrugs.com. Eliquis is one of the most widely prescribed oral anticoagulants in the United States and one of the largest brands in the space to be offered on the site, which allows patients to purchase prescription medicines directly at reduced costs, providing another ave…

Bristol Myers Squibb and Pfizer Expand Eliquis Access via Mark Cuban Cost Plus Drug Company

The Bristol Myers Squibb-Pfizer Alliance has announced a strategic collaboration with the Mark Cuban Cost Plus Drug Company to offer Eliquis (apixaban) directly to consumers. Starting April 27, 2026, cash-paying patients can purchase a 30-day supply of the widely prescribed blood thinner for $345 through the online platform. This initiative aims to enhance price transparency and provide a more affordable, direct-to-patient channel for those mana…

Bristol Myers Squibb and Pfizer to make Eliquis (apixaban) available via Mark Cuban Cost Plus Drug Co.

PRINCETON, N.J. — The Bristol Myers Squibb-Pfizer Alliance today announced the launch of a collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to offer Eliquis (apixaban) on CostPlusDrugs.com. Eliquis is one of the most widely prescribed oral anticoagulants in the United States and one of the largest brands in the space to be offered on the site, which allows patients to purchase prescription medicines directly at reduced cost…